|
業務類別
|
Medical Devices |
|
業務概覽
|
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems. |
| 公司地址
| 16 Hartum Street, 14th Floor, RAD Tower, Har HaHotzvim, Jerusalem, ISR, 9777516 |
| 電話號碼
| +972 25824030 |
| 傳真號碼
| +972 25812517 |
| 公司網頁
| https://www.brainsway.com |
| 員工數量
| 129 |
| Dr. Yiftach Roth |
Chief Scientist |
-- |
20/04/2026 |
| Mr. Hadar Levy |
Chief Executive Officer |
美元 313.76K |
20/04/2026 |
| Ms. Colleen Hanlon, PhD |
Vice President of Medical Affairs |
美元 240.00K |
20/04/2026 |
| Mr. Gilead Moiseyev |
Chief Technology Officer |
美元 184.31K |
20/04/2026 |
| Mr. Ido Marom |
Chief Financial Officer |
美元 215.98K |
20/04/2026 |
| Ms. Naomi Rozenfeld |
Chief Marketing Officer |
-- |
20/04/2026 |
| Mr. Michael Cohen |
Vice President of US Sales |
美元 200.00K |
22/04/2025 |
|
|
| Ms. Karen Sarid |
Independent Director |
20/04/2026 |
| Dr. David Zacut |
Vice Chairman of the Board |
20/04/2026 |
| Ms. Eti Mitrany |
Independent Director |
20/04/2026 |
| Professor Abraham Zangen |
Director |
20/04/2026 |
| Mr. Avner Lushi |
Independent Director |
20/04/2026 |
| Mr. Jonathan K. Shulkin |
Director |
20/04/2026 |
| Mr. Amiram Boehm |
Chairman of the Board |
20/04/2026 |
|
|
|
|
